In July 2020, we surveyed over 2,000 consumers to understand how the pandemic has transformed their views on health and digital health services and what this means for life sciences companies and healthcare providers. The research (Title: The Health Fix) was conducted by the Capgemini Research Institute.
In September, we organized a debate on the two most important conclusions:
- Consumers increasingly demand digital health and low-touch healthcare options
- Empowered consumers proactively embrace technology now more than ever, but may be reluctant to start new therapies.
The big question is: what does this mean for life sciences companies; what are the consequences?
Capgemini experts Olivier Zitoun, Matt Smith, Eliza Silvester and Aaron Stancik and Michel Reid, both from GlaxoSmithKline, engaged in a lively discussion. We invite you to listen to the debate and find out yourself. And since “a picture is worth more than a 1,000 words,” we had a cartoonist join the debate to create a summary. The results of that can be seen here:
Contact us for more information.